Simplifying Diet Tracking in a Digital Weight Loss Intervention
Simplifying Dietary Self-Monitoring in a Digital Weight Loss Intervention
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 18 Years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
- Time periods mentioned: 12 months
- Procedures mentioned: Questionnaires
Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.
Show the study's own words
- "In essence, this is a head-to-head comparison of two tracking approaches; the investigators are evaluating whether weight loss is comparable over 12 months, or whether one approach will have greater weight loss."
- "Assessment of body weight and survey measures will occur at the beginning of the trial ("baseline"), and at 1, 6, 12, and 18 months."
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study compares two ways to track food in a 12-month online weight loss program: tracking only high-calorie, low-nutrient foods or tracking all foods and calories. It is for adults with overweight or obesity who live in the United States. Researchers will compare weight loss between the two groups.
The purpose of this study is to compare two approaches for tracking dietary intake in a 12-month fully digital weight loss intervention: (1) Simplified approach: track Red Zone Foods (e.g., foods high in calories and low in nutritional value) vs. (2) Detailed approach: track all foods and their corresponding calories. In essence, this is a head-to-head comparison of two tracking approaches; the investigators are evaluating whether weight loss is comparable over 12 months, or whether one approach will have greater weight loss. The investigators will recruit 328 adults. Broadly, adults with overweight or obesity who live in the United States will be eligible. The weight loss intervention will last 12 months. All participants will be asked to track their dietary intake + body weight + steps daily as well as complete weekly behavioral lessons and action plans to promote healthy eating and physical activity. All study tasks will occur remotely. Assessment of body weight and survey measures will occur at the beginning of the trial ("baseline"), and at 1, 6, 12, and 18 months.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- Are age 18 or older and live in the United States.
- Have a body mass index (BMI) of 25 to 45. BMI is a measure based on height and weight.
- Own a smartphone and are willing to install a study app on it.
- Have access to a personal email account.
- Can use English or Spanish.
- Want to lose weight by changing daily habits.
- Are willing to have your study group chosen by chance.
Who can't join
- Are in another weight loss program, take weight loss medicine, or lost 5% or more of your weight in the past 6 months.
- Have had weight loss surgery or plan to have it during the study.
- Are pregnant, plan to become pregnant during the study, were pregnant in the past 6 months, or are breastfeeding or making breast milk.
- Live with someone else who is in this study.
- Were hospitalized for a mental health condition in the past 12 months.
- Cannot do moderate exercise, such as brisk walking.
- Have a health condition or take medicine that makes this program unsuitable. Examples include severe kidney disease, cancer, schizophrenia, dementia, steroid use, or medicines for psychosis.
- Need a different or more intensive program, or the study doctor has safety concerns. Examples include a past eating disorder or serious heart or blood vessel event, or blood pressure or diabetes that is not controlled.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria: * adults (ages 18+ years) * body mass index (BMI) 25.0 to 45.0 kg/m\^2 * smartphone ownership * willing to install a mobile app on personal smartphone * access to a personal email account * English or Spanish language proficiency * interest in losing weight through behavioral strategies * living in the United States * willing to be randomized Exclusion Criteria: * concurrent enrollment in another weight management intervention * loss of ≥5% weight in the past 6 months * prior or planned bariatric surgery during the trial period * current or planned pregnancy during the trial period, or recent pregnancy in the past 6 months * currently breastfeeding or lactating * current use of anti-obesity medications * living with someone else participating in the study * hospitalization for a mental health condition in the past 12 months * inability to engage in moderate forms of physical activity akin to brisk walking * medical or psychiatric contraindication (e.g., end stage renal disease, cancer, schizophrenia, dementia, use of steroids, use of antipsychotic medication) * if an individual would be better suited for a more intensive or different type of intervention based on a health condition (e.g., individuals with history of an eating disorder or cardiovascular event, uncontrolled hypertension, or uncontrolled diabetes mellitus) * investigator discretion for safety reasons
Study sites (1)
CA
- Stanford University School of Medicine · Palo Alto, CA 94304More trials in Palo Alto